CRA II

Responsible for project activities associated with monitoring functions of Phase I through Phase IV clinical research studies and Real World Evidence (RWE) studies, while continuing to develop knowledge of drug development process, International Council for Harmonisation (ICH) /  Good Clinical Practice (GCP), and relevant regulations.

Performs management of study site activities in adherence to all applicable regulatory guidelines and Standard Operating Procedures (SOPs).